Correction: Prognostic significance of inflammation-based markers in nasopharyngeal carcinoma: a systematic review and meta-analysis - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: The Role of Inflammation-Related Markers as Prognostic Indicators in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis

  • By

  • Yajun Wang

  • Leyu Zhang

  • Qianyu Liu

  • Yi Wu

  • August 21, 2026

Share

Correction: The Role of Inflammation-Related Markers as Prognostic Indicators in Nasopharyngeal Carcinoma

Background

Inflammation is a critical factor in tumor progression and prognosis. In nasopharyngeal carcinoma, inflammation-derived hematological markers have emerged as potential prognostic indicators. Understanding these markers can aid in assessing patient outcomes.

Data Highlights

No numerical or trial data is provided in the correction notice.

Key Findings

  • The original article contained a formatting error in Figure 1.
  • The corrected figure is now presented to ensure proper visual representation.
  • The systematic review and meta-analysis assess inflammation-derived indices in NPC.
  • Inflammation-related markers may serve as prognostic factors in NPC.
  • Current guidelines emphasize EBV-related measures as key prognostic indicators in NPC.

Clinical Implications

The correction of the figure enhances the clarity of the findings regarding inflammation-related markers in NPC.

Conclusion

The correction ensures accurate representation of the findings related to inflammation markers in NPC.

Related Resources & Content

  1. Wang Y, Zhang L, Liu Q, Wu Y, Frontiers in Oncology, 2026 -- Correction: The Role of Inflammation-Related Markers as Prognostic Indicators in Nasopharyngeal Carcinoma
  2. Frontiers in Oncology — Distinct roles of nutritional and inflammatory signatures in predicting pathological response versus long-term survival in locally advanced gastric cancer treated with neoadjuvant immunotherapy
  3. Frontiers in Oncology — Inflammatory biomarker-based prognostic model for immunotherapy outcomes in patients with recurrent or metastatic cervical cancer
  4. Frontiers in Oncology — Inflammatory indexes as prognostic biomarkers in advanced triple negative breast cancer patients
  5. SEOM-TTCC clinical guideline for nasopharyngeal carcinoma (update 2025) - PubMed
  6. Review
  7. Frontiers | Prognostic significance of inflammation-based markers in nasopharyngeal carcinoma: a systematic review and meta-analysis

Original Source(s)

Related Content